Third, drug tolerance and drug-drug interactions: Cancer cells may compensate for the inhibitory effects of ABCC5 through other resistance mechanisms, and the developed inhibitors may face rapidly emerging drug tolerance. The gene discussed is ABCC5; the disease is cancer.